NDC product
Post - Vaccination
NDC 55714-2572 · Newton Laboratories, Inc.
Key facts
| Product NDC | 55714-2572 |
|---|---|
| Proprietary name | Post - Vaccination |
| Nonproprietary name | Influenzinum, Morbillinum, Pertussinum, Aconitum nap., Alumina, Antimon. tart., Arsenicum alb., Baptisia, Belladonna, Bryonia, Cinchona, Crotalus horridus and 17 more |
| Substances | INFLUENZA A VIRUS, INFLUENZA B VIRUS, MEASLES VIRUS, HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED, ACONITUM NAPELLUS, ALUMINUM OXIDE, ANTIMONY POTASSIUM TARTRATE, ARSENIC TRIOXIDE, BAPTISIA TINCTORIA ROOT, ATROPA BELLADONNA, BRYONIA ALBA ROOT, CINCHONA OFFICINALIS BARK and 18 more |
| Dosage form | LIQUID |
| Route | ORAL |
| Labeler | Newton Laboratories, Inc. |
| Product type | HUMAN OTC DRUG |
| Marketing category | UNAPPROVED HOMEOPATHIC |
| Pharmacologic classes | Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC] and 3 more |
| Marketing start | May 3, 2021 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: